Historique
Bulletin de Périodique
International Journal of Drug Policy , Vol.52 - February 2018
Paru le :
01/02/2018
Article en page(s) :
1-122
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Down the local: A qualitative case study of daytime drinking spaces in the London Borough of Islington. Thompson C., Milton S., Egan M., Lock K., p. 1-8.
- Chemsex, risk behaviours and sexually transmitted infections among men who have sex with men in Dublin, Ireland. Glynn R.W., Byrne N., O'Dea S., Shanley A., Codd M., Keenan E., et al., p. 9-15.
- Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia. Kikvidze T., Luhmann N., Avril E., Butsashvili M., Labartkava K., Etienne A., et al., p. 16-19.
- Re-thinking pre-drinking: Implications from a sample of teenagers who drink in private settings. Wilson J., Ogeil R.P., Lam T., Lenton S., Lloyd B., Burns L., et al., p. 20-24.
- The relationship between Australian harm minimisation alcohol education and student uptake, consumption and harm. Midford R., Lester L., Williams T., White V., p. 25-31.
- Experiences with compulsory drug detention among people who inject drugs in Bangkok, Thailand: A qualitative study. Kerr T., Small W., Ayutthaya P.P.N., Hayashi K., p. 32-38.
- Kalaban: Young drug users' engagements with law enforcement in the Philippines. Lasco G., p. 39-44.
- Associations between medical cannabis and other drug use among unstably housed women. Meacham M.C., Ramo D.E., Kral A.H., Riley E.D., p. 45-51.
- Identifying gaps in the implementation of naloxone programs for laypersons in the United States. Lambdin B.H., Zibbell J., Wheeler E., Kral A.H., p. 52-55.
- Perceptions about supervised injection facilities among people who inject drugs in Philadelphia. Harris R.E., Richardson J., Frasso R., Anderson E.D., p. 56-61.
- Becoming a medical marijuana user. Lankenau S.E., Kioumarsi A., Reed M., McNeeley M., Iverson E., Wong C.F., p. 62-70.
- The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives. Soussan C., Andersson M., Kjellgren A., p. 71-78.
- Ordering clinical realities: Controversy and multiplicity in alcohol and other drug treatment for young adults. Hart A., p. 79-86.
- Routes of administration for cannabis use - basic prevalence and related health outcomes: A scoping review and synthesis. Russell C., Rueda S., Room R., Tyndall M., Fischer B., p. 87-96.
- Multiple injections per injection episode: High-risk injection practice among people who injected pills during the 2015 HIV outbreak in Indiana. Broz D., Zibbell J., Foote C., Roseberry J.C., Patel M.R., Conrad C., et al., p. 97-101.
- Interpreting the Czech drug decriminalization: The glass is half full - Response to Cerveny, J., Chomynova, P., Mravcik, V., & van Ours, J.C. (2017). Cannabis decriminalization and the age of onset of cannabis use. Belackova V., Stefunkova M., p. 102-105.
- Being in control? A thematic content analysis of 14 in-depth interviews with 2,4-dinitrophenol users. Ainsworth N.P., Vargo E.J., Petroczi A., p. 106-114.
- Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era. Valerio H., McAuley A., Innes H., Palmateer N., Goldberg D.J., Munro A., et al., p. 115-122.
- Down the local: A qualitative case study of daytime drinking spaces in the London Borough of Islington. Thompson C., Milton S., Egan M., Lock K., p. 1-8.
- Chemsex, risk behaviours and sexually transmitted infections among men who have sex with men in Dublin, Ireland. Glynn R.W., Byrne N., O'Dea S., Shanley A., Codd M., Keenan E., et al., p. 9-15.
- Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia. Kikvidze T., Luhmann N., Avril E., Butsashvili M., Labartkava K., Etienne A., et al., p. 16-19.
- Re-thinking pre-drinking: Implications from a sample of teenagers who drink in private settings. Wilson J., Ogeil R.P., Lam T., Lenton S., Lloyd B., Burns L., et al., p. 20-24.
- The relationship between Australian harm minimisation alcohol education and student uptake, consumption and harm. Midford R., Lester L., Williams T., White V., p. 25-31.
- Experiences with compulsory drug detention among people who inject drugs in Bangkok, Thailand: A qualitative study. Kerr T., Small W., Ayutthaya P.P.N., Hayashi K., p. 32-38.
- Kalaban: Young drug users' engagements with law enforcement in the Philippines. Lasco G., p. 39-44.
- Associations between medical cannabis and other drug use among unstably housed women. Meacham M.C., Ramo D.E., Kral A.H., Riley E.D., p. 45-51.
- Identifying gaps in the implementation of naloxone programs for laypersons in the United States. Lambdin B.H., Zibbell J., Wheeler E., Kral A.H., p. 52-55.
- Perceptions about supervised injection facilities among people who inject drugs in Philadelphia. Harris R.E., Richardson J., Frasso R., Anderson E.D., p. 56-61.
- Becoming a medical marijuana user. Lankenau S.E., Kioumarsi A., Reed M., McNeeley M., Iverson E., Wong C.F., p. 62-70.
- The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives. Soussan C., Andersson M., Kjellgren A., p. 71-78.
- Ordering clinical realities: Controversy and multiplicity in alcohol and other drug treatment for young adults. Hart A., p. 79-86.
- Routes of administration for cannabis use - basic prevalence and related health outcomes: A scoping review and synthesis. Russell C., Rueda S., Room R., Tyndall M., Fischer B., p. 87-96.
- Multiple injections per injection episode: High-risk injection practice among people who injected pills during the 2015 HIV outbreak in Indiana. Broz D., Zibbell J., Foote C., Roseberry J.C., Patel M.R., Conrad C., et al., p. 97-101.
- Interpreting the Czech drug decriminalization: The glass is half full - Response to Cerveny, J., Chomynova, P., Mravcik, V., & van Ours, J.C. (2017). Cannabis decriminalization and the age of onset of cannabis use. Belackova V., Stefunkova M., p. 102-105.
- Being in control? A thematic content analysis of 14 in-depth interviews with 2,4-dinitrophenol users. Ainsworth N.P., Vargo E.J., Petroczi A., p. 106-114.
- Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era. Valerio H., McAuley A., Innes H., Palmateer N., Goldberg D.J., Munro A., et al., p. 115-122.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
S. E. LANKENAU ;
A. KIOUMARSI ;
M. REED ;
M. MCNEELEY ;
E. IVERSON ;
C. F. WONG
|
2018
Dans International Journal of Drug Policy (Vol.52, February 2018) Article : Périodique
Dans International Journal of Drug Policy (Vol.52, February 2018) Article : Périodique
Background: Since marijuana became legal for medical use in California in 1996, reasons for medical use among medical marijuana patients (MMP) have become increasingly well described in qualitative studies. However, few studies have detailed how[...]
C. SOUSSAN ;
M. ANDERSSON ;
A. KJELLGREN
|
2018
Dans International Journal of Drug Policy (Vol.52, February 2018) Article : Périodique
Dans International Journal of Drug Policy (Vol.52, February 2018) Article : Périodique
Background: The increasing number of legally ambiguous and precarious Novel Psychoactive Substances (NPS) constitutes a challenge for policy makers and public health. Scientific and more in-depth knowledge about the motivations for using NPS is [...]
C. RUSSELL ;
S. RUEDA ;
R. ROOM ;
M. TYNDALL ;
B. FISCHER
|
2018
Dans International Journal of Drug Policy (Vol.52, February 2018) Article : Périodique
Dans International Journal of Drug Policy (Vol.52, February 2018) Article : Périodique
Background: Cannabis use is common, and associated with adverse health outcomes. 'Routes of administration' (ROAs) for cannabis use have increasingly diversified, in part influenced by developments towards legalization. This paper sought to revi[...]